Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Completed · Phase 3 · Has a placebo group

Conditions studied: Multiple Sclerosis

In brief

The purpose of the study is to show that individuals treated with Fampridine-SR tablets are significantly more likely to have consistent improvements in their walking than those treated with placebo tablets.

Key facts

Study ID

NCT00483652

Run by

Acorda Therapeutics

People needed

240

Starts

2007-05-01

Expected to finish

2008-05-01

Last updated by the study team

2016-02-04

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with clinically defined multiple sclerosis
• All patients must be able to complete two trials of a timed 25 foot walk

You may not qualify if…

• Female patients who are either pregnant or breastfeeding.

Where it is running

• Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
• HOPE Research Institute — Phoenix, Arizona, United States
• Neurological Associates — Fayetteville, Arkansas, United States
• Alta Bates Summit Medical Center - Research and Education Institute — Berkeley, California, United States
• USC, Keck School of Medicine Health Care Consultation Center — Los Angeles, California, United States
• UC Davis — Sacramento, California, United States
• Yale University MS Center — New Haven, Connecticut, United States
• Shepherd Center — Atlanta, Georgia, United States
• Consultants in Neurology, Ltd. — Northbrook, Illinois, United States
• Indiana University MS Center — Indianapolis, Indiana, United States
• Associates in Neurology, PSC — Lexington, Kentucky, United States
• Maryland Center for MS — Baltimore, Maryland, United States
• Lahey Clinic — Lexington, Massachusetts, United States
• The Schapiro Center for MS — Golden Valley, Minnesota, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Advanced Neurology Specialists — Great Falls, Montana, United States
• UMDNJ — Newark, New Jersey, United States
• Gimbel MS Center at Holy Name Hospital — Teaneck, New Jersey, United States
• Jacobs Neurological Institute Buffalo General Hospital — Buffalo, New York, United States
• Corinne Goldsmith Dickinson Center for MS — New York, New York, United States
• Columbia University Multiple Sclerosis Clinical Care Center — New York, New York, United States
• University of Rochester — Rochester, New York, United States
• SUNY Stony Brook — Stony Brook, New York, United States
• CMC - Neuroscience & Spine Institute, Division of Neurology — Charlotte, North Carolina, United States
• Raleigh Neurology Associates — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.